Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

FDA approves Trelegy Ellipta for asthma

Sep. 14, 2020

Phase III trial of Fasenra in nasal polyposis meets coprimary endpoints

Sep. 14, 2020

QBW-251: a CFTR potentiator in phase II for the treatment of COPD

Sep. 14, 2020

Results from a phase IIa POC trial of the oral adenosine A1 receptor antagonist PBF-680

Sep. 9, 2020

First phase I data presented for the neutrophil elastase inhibitor BI-1323495

Sep. 9, 2020

New personalized cystic fibrosis treatment treats Class V mutations

Sep. 9, 2020

Palobiofarma reports promising phase II data on PBF-680 for asthma

Sep. 7, 2020

Beijing Sanyou Liheze Biological Technology discovers potential stem cell therapy for COPD

Sep. 4, 2020

Nocion begins healthy volunteer study of NOC-100 for cough

Sep. 3, 2020

Cartesian initiates first-in-human study of Descartes-30 in patients with ARDS and COVID-19

Sep. 3, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Researchers hit back after colleagues removed from ADA meeting
BioWorld
Former principal officers of the American Diabetes Association (ADA) have hit back at the association’s board and CEO after it prohibited the distribution of an...